Press Release 2024 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Enhancing Adult Health in Vietnam: Sabinsa’s Contribution to Joint Health with Boswellin®

Dr. Anju Majeed, Sami-Sabinsa Executive Chairperson, Welcomes President of the Republic of Maldives at the India-Maldives Business Forum

UNPA Honors Sami-Sabinsa’s Global CEO Shaheen Majeed and Late Founder Dr. Muhammed Majeed

Sabinsa and Postbiotics Inc. announce a Multinational Distribution Agreement for the Postbiotic Dietary Supplement Ingredient PoZibio®

Jeanette Fisher Joins Sabinsa as Marketing Director

Sabinsa USA Adds Sales Manager and Utah Facility Operations Staff

Certificates

Global Offices

Get in Touch

Disclaimer